Atherosclerotic Disease in Marked Hyperalphalipoproteinemia

201 patients (111 males and 90 females) with marked hyperalphalipoproteinemia (HALP) (≥ 2.58 mmol/L [100 mg/dL]), mean age 54 ± 15 years, 67% of whom had CETP gene mutations.

Incidence of atherosclerotic cardiovascular disease (ACD) and lipoprotein abnormalitieshard clinical